Sickle cell disease care shows significant global disparities

Research and clinical studies are highlighting significant global disparities in the management of sickle cell disease (SCD). Pediatric hematologist Baba Inusa, of King's College London, has noted that disease patterns, treatment access, and pain outcomes vary significantly between sub-Saharan Africa, other low- and middle-income countries (LMICs), and high-income countries (HICs).

Despite patients in high-income regions like the US and UK often sharing similar backgrounds with those in Africa, differences exist in therapy adherence and patient responses. These variations are attributed to differing healthcare systems and funding approaches across various geographic settings.

In a separate study involving the ASH Research Collaborative Data Hub, researchers found a high level of concordance between physician attestation and manual data abstraction regarding sickle cell types, suggesting reliability in clinical data reporting for the condition.